New Delhi: The prices of Serum Institute’s Covid vaccine COVISHIELD and Bharat Biotech’s COVAXIN have been slashed significantly. CEO of Serum Institute of India, SII Adar Poonawalla said in a …
Covishield, Covaxin price cut to Rs 225 per dose for private hospitals Read More
New Delhi: The subject expert committee (SEC) of Drugs controller General (India) has recommended that Hyderabad-based Bharat Biotech can conduct phase- three trials on its intranasal vaccine. The company had …
Bharat Biotech gets nod to conduct phase-3, booster trial of intranasal vaccine Read More
New Delhi: COVID-19 vaccination for children in the age group of 15 to 18 years has begun all over the country. The vaccine option for children is only Covaxin for …
Covid Vaccination of children between 15 and 18 years begins from today Read More
New Delhi: Bharat Biotech’s COVID-19 vaccine ‘Covaxin’ has received approval for Emergency use in children between 12 to 18 years of age. In a statement, Bharat Biotech said, Covaxin is …
Bharat Biotech’s Covaxin gets nod for emergency use in children Read More
New Delhi, The National Regulator of the country, the Drugs Controller General of India (DCGI), after careful examination, has accepted the recommendation of Subject Expert Committee (SEC) and accorded permission …
DCGI approves Phase 2,3 clinical trial of Covaxin in the age group of 2 to 18 Years Read More
Bhubaneswar: Preparations for launching the much-awaited Covid-19 vaccine on Saturday have been completed at the Institute of Medical Sciences and SUM Hospital, faculty of medicine of Siksha ‘O’ Anusandhan (SOA). …
IMS AND SUM Hospital prepared for lunch of COVID Vaccine on Saturday Read More
Bhubaneswar: The third phase human trial of Covid-19 vaccine candidate ‘Covaxin’ began at the Institute of Medical Sciences and SUM Hospital here, said an official on Friday. This is the only …
Phase-3 trial of Covaxin begins at Odisha’s SUM Hospital Read More
Chandigarh: Haryana Health Minister Anil Vij was administered a trial dose of India-made coronavirus vaccine Covaxin on Friday. He was among the first volunteers for the third phase trial of the …
Haryana health minister Vij gets trial dose of Covid vaccine Read More Hyderabad: Even as India’s first indigenous coronavirus vaccine Covaxin is entering its third phase of human trials, Bharat Biotech on Monday raised the logistical query on “how to vaccinate 1.3 billion …
Vaccinating 130Cr people with injectable Covaxin a challenge: Bharat Biotech Read More
Bhubaneswar: The third phase of the human trial of COVAXIN, the much-awaited indigenous vaccine being developed against Covid-19, will commence at the Institute of Medical Sciences and SUM Hospital here …
Third phase human trial of Covaxin to commence at IMS and SUM Hospital soon Read More